WallStreetZenWallStreetZen

NASDAQ: INCY
Incyte Corp Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Incyte earnings were $1.4B for the trailing 12 months ending Mar 31, 2026, with 2,413.8% growth year over year. The latest INCY earnings report on Mar 31, 2026 announced Q1 2026 earnings of $303.3M, up 1.4% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, INCY reported annual earnings of $1.3B, with 3,845% growth.

INCY past earnings growth

How has INCY's earnings growth performed historically?

Company
2,413.79%
Industry
59.12%
Market
90.49%
INCY's earnings have grown faster... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
INCY's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance
INCY's earnings growth is accelerating... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

INCY earnings history

Current Revenue
$5.4B
Current Earnings
$1.4B
Current Profit Margin
26.7%
INCY's has demonstrated consistent long-term... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

INCY Return on Equity

Current Company
29.2%
Current Industry
-5.4%
Current Market
12.2%
INCY's Return on Equity (29.2%)... subscribe to Premium to read more.
High Return on Equity Performance

INCY Return on Assets

Current Company
21.7%
Current Industry
-14.9%
INCY is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when INCY announces earnings.

INCY Return on Capital Employed

Current Company
30.37%
Current Industry
-10%
INCY has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

INCY vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
INCY$1.87B$1.43B+27.19%$7.29
ROIV-$712.42M-$809.24MN/A-$1.17
MRNA-$2.90B-$3.19BN/A-$8.15
GMAB$1.54B$963.00M+8.69%$1.55
BNTX-$703.76M-$1.34BN/A-$5.53
View Top Biotech Stocks

Incyte Earnings Reports & History FAQ

What were Incyte's earnings last quarter?

On INCY's earnings call on Invalid Date, Incyte (NASDAQ: INCY) reported Q1 2026 earnings per share (EPS) of $1.52, up 85.37% year over year. Total INCY earnings for the quarter were $303.33 million. In the same quarter last year, Incyte's earnings per share (EPS) was $0.82.

If you're new to stock investing, here's how to buy Incyte stock.

Is Incyte profitable or losing money?

As of the last Incyte earnings report, Incyte is currently profitable. Incyte's net profit (also called net income) for the twelve months ending Mar 31, 2026 was $1.43 billion, a 6,631.44% increase year over year.

What was INCY's earnings growth in the past year?

As of Incyte's earnings date in Invalid Date, Incyte's earnings has grown 2,413.79% year over year. This is 2,354.67 percentage points higher than the US Biotechnology industry earnings growth rate of 59.12%. INCY earnings in the past year totalled $1.43 billion.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.